Calpromotin, a cytoplasmic protein, is associated with the formation of dense cells in sickle cell anemia

American Journal of Hematology

Volumn 56, Issue 2, 1997, Pages 100-106

  Moore, R Blaine ^a   Shriver, Stephanie K ^a   Jenkins, Lucy D ^a   Mankad, Vipul N ^b   Shah, Arvind K ^a   Plishker, Gordon A ^c  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c SAM HOUSTON STATE UNIVERSITY   (United States)

Author keywords

Calcium; Erythrocytes; Potassium channels; Sickle cell disease

Indexed keywords

CYTOPLASM PROTEIN; POTASSIUM CHANNEL;

ARTICLE; CELL DENSITY; CORRELATION FUNCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; BLOOD CELLS; BLOOD PROTEINS; CARRIER PROTEINS; ERYTHROCYTE MEMBRANE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON;

EID: 0030761062     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199710)56:2<100::AID-AJH5>3.0.CO;2-2     Document Type: Article

References (38)

1. Mankad VN, Williams JP, Harpen MD, Manci E, Longenecker G, Moore RB, Shah A, Yang YM, Brogdon BG: Magnetic resonance imaging of bone marrow in sickle cell disease: Clinical, hematologic, and pathologic correlations. Blood 75:274, 1990.
2. Bookchin RM, Ortiz OE, Lew VL: Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 240:193, 1987.
3. Wolff D, Cecchi X, Spalvins A, Canessa M: Charybdotoxin blocks with high affinity the Ca-activated K+ channel of Hb A and Hb S red cells: Individual differences in the number of channels. J Membr Biol 106:243, 1988.
4. Lux SE: Spectrin-actin membrane skeleton of normal and abnormal red blood cells. Semin Hematol 16:21, 1979.
5. Moore RB: Pathophysiology of the sickle cell. In Mankad VN, Moore RB (eds): "Sickle Cell Anemia: Pathophysiology. Diagnosis and Management." Westport, CT: Praeger Publishers, 1992, p 44.
6. Brugnara C, De Franceschi L, Alper SL: Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 92:520, 1993.
7. Engelmann B: Calcium homeostasis of human erythrocytes and its pathophysiological implications. Klin Wochenschr 69:137, 1991.
8. Olivieri O, Vitoux D, Bachir D, Beuzard Y: K+ efflux in deoxygenated sickle cells in the presence or absence of DIOA, a specific inhibitor of the [K+, Cl-] cotransport system. Br J Haematol 77:117, 1991.
9. Vitoux D, Olivieri O, Garay RP, Cragoe EJ, Jr., Galacteros F, Beuzard Y: Inhibition of K+ efflux and dehydration of sickle cells by alkanoic acid: An inhibitor of the K+ Cl-cotransport system. Proc Natl Acad Sci USA 86:4273, 1989.
10. Apovo M, Beuzard Y, Galacteros F, Bachir D, Giraud F: The involvement of the Ca-dependent K channel and of the KCI co-transport in sickle cell dehydration during cyclic deoxygenation. Biochim Biophys Acta 1225:255, 1994.
11. + transport in erythrocyte membrane vesicles requires a cytoplasmic protein. J Biol Chem 266:18964, 1991.
12. ++ with fluo-3. Cytometry 11: 923, 1990.
13. Plishker GA, White PA, Cadman ED: Involvement of a cytoplasmic protein in calcium-dependent potassium efflux in red blood cells. Am J Physiol 251:C535, 1986.
14. Plishker PA: Iodoacetic acid inhibition of calcium-dependent potassium efflux in red blood cells. Am J Physiol 248:C419, 1985.
15. Ohnishi ST, Katagi H, Katagi C: Inhibition of the in vitro formation of dense cells and of irreversibly sickled cells by charybdotoxin, a specific inhibitor of calcium-activated potassium efflux. Biochim Biophys Acta 1010:199, 1989.
16. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680, 1970.
17. Moore RB, Plishker GA, Shriver SK: Purification and measurement of calpromotin, the cytoplasmic protein which activates calcium-dependent potassium transport. Biochem Biophys Res Commun 166: 146, 1990.
18. Horiuchi K, Asakura T: Formation of light irreversibly sickled cells during deoxygenation-oxygenation cycles. J Lab Clin Med 110:653, 1987.
19. Etzion Z, Tiffert T, Bookchin RM, Lew VL: Effects of deoxygenation on active and passive calcium transport and on the cytoplasmic calcium levels of sickle cell anemia red cells. J Clin Invest 92:2489, 1993.
20. Tiffert T, Etzion Z, Bookchin RM, Lew VL: Effects of deoxygenation on active and passive calcium transport and cytoplasmic calcium buffering in normal human red cells. J Physiol 464:529, 1993.
21. Tiffert T, Garcia-Sancho J, Lew VL: Irreversible ATP depletion caused by low concentrations of formaldehyde and of calcium-chelator esters in intact human red cells. Biochim Biophys Acta 773:143, 1984.
22. Eaton JW, Berger E, White JG, Jacob HS: Calcium-induced damage of haemoglobin SS and normal erythrocytes. Br J Haematol 38:57, 1978.
23. Steinberg MH, Eaton JW, Berger E, Coleman MB, Oelshlegel FJ: Erythrocyte calcium abnormalities and the clinical severity of sickling disorders. Br J Haematol 40:533, 1978.
24. Eaton JW, Skelton TD, Swofford HS, Kolpin CE, Jacob HS: Elevated erythrocyte calcium in sickle cell disease. Nature 246:105, 1973.
25. Palek J, Thomae M, Ozog D: Red cell calcium content and transmembrane calcium movements in sickle cell anemia. J Lab Clin Med 89: 1365, 1977.
26. Palek J: Calcium accumulation during sickling of hemoglobin S (HbSS) red cells. Blood 42:988, 1973.
27. Bookchin RM, Lew VL: Progressive inhibition of the Ca pump and Ca:Ca exchange in sickle red cells. Nature 284:561, 1980.
28. + in sickle cells. Cell Calcium 6:397, 1985.
29. Lew VL, Hockaday A, Sepulveda MI, Somlyo AP, Somlyo AV, Ortiz OE, Bookchin RM: Compartmentalization of sickle-cell calcium in endocytic inside-out vesicles. Nature 315:586, 1985.
30. Murphy E, Berkowitz LR, Orringer E, Levy L, Gabel SA, London RE: Cytosolic free calcium levels in sickle red blood cells. Blood 69:1469, 1987.
31. + transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease. J Clin Invest 93:1670, 1994.
32. Mankad VN, Moore RB: Reduction in morphological sickling of red cells incubated with quinine. Pediatr Hematol Oncol 4:73, 1987.
33. Ohnishi ST, Horiuchi KY, Horiuchi K: The mechanism of in vitro formation of irreversibly sickled cells and modes of action of its inhibitors. Biochim Biophys Acta 886:119, 1986.
34. Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, Alper SL: Therapy with oral clotrimazole induces inhibition of the gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 97:1227, 1996.
35. Bookchin RM, Ortiz OE, Lew VL: Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J Clin Invest 87:113, 1991.
36. Bookchin RM, Ortiz OE, Freeman CJ, Lew VL: Predictions and tests of a new integrated reticulocyte model: Implications for dehydration of sickle cells. Prog Clin Biol Res 319:615, 1989.
37. + efflux is highly expressed in young human red cells containing normal hemoglobin or HbS. J Membr Biol 97:97, 1987.
38. Franco RS, Palascak M, Thompson H, Rucknagel DL, Joiner CH: Dehydration of transferrin receptor-positive sickle reticulocytes during continuous or cyclic deoxygenation: Role of KCl cotransport and extracellular calcium. Blood 88:4359, 1996.